Dr. Mineishi is known internationally for his work in bone marrow transplantation, particularly in regards to aggressive AML.  He has focused on graft versus host disease, complications after stem cell transplantation, reduced intensity stem cell transplantation, and HLA-mismatch stem cell transplantation.

His work has been published in journals such as JAMA, Blood, Cancer Research, Clinical Cancer Research, and the British Journal of Haematology. He has presented his work at numerous Bone Marrow Transplantation and Hematology meetings throughout the world.

Dr. Mineishi received his MD degree from the University of Tokyo in Japan, and has been affiliated with St. Luke International Hospital in Tokyo, MD Anderson Cancer Center in Houston, Texas, Long Island Jewish Medical Center and Memorial Sloan-Kettering Cancer Center in New York, the University of Wisconsin, the National Cancer Center Hospital in Tokyo, Vanderbilt University Medical Center, and the University of Michigan at Ann Arbor.

For more information about Dr. Mineishi, please click here.

Dr. Salzman graduated from Louisiana State University School of Medicine in New Orleans, and has been affiliated with the University of Texas Health Science Center at San Antonio before coming to UAB.

She currently serves as the Associate Professor and Director of Education and Clinical Services of the Bone Marrow Transplantation & Cell Therapy Program at UAB.  She also serves as the Associate Chief of Staff and Associate Quality Manager for Blood Management for the University Hospital, in addition to being the Co-Director of the Blood Management Committee and an Inspector of Foundation for the Accreditation of Cellular Therapy (FACT).

For more information on Dr. Salzman, please click here.

Dr. Innis-Shelton’s focus is on health disparities and translational clinical trial development.  She is interested in translational research and has partnered with the minority health consortium at UAB.

Dr. Innis-Shelton received her MD degree from the Medical College of Georgia, and has been affiliated with Atlanta Medical Center, Palomar Medical Center in Escondido, California, the Cancer Center of Guam in Tamuning, and the University of Virginia in Charlottesville before being appointed Assistant Professor of Medicine for the Bone Marrow Transplantation & Cell Therapy at UAB.

For more information on Dr. Innis-Shelton, please click here.


Lawrence S. Lamb, PhD

Dr. Lamb received his PhD from the University of South Carolina School of Medicine.  He has been affiliated with Richland Memorial Hospital in South Carolina and the South Carolina Cancer Center.  His primary research interest is cell-based immunotherapy of cancer.

He is currently the Director of the Cell Therapy Laboratory and Associate Director of the Hematopoietic Stem Cell Processing Facility for the Bone Marrow Transplantation Program at UAB’s School of Medicine.  He has also been sub-appointed as an Associate Professor of Pathology, and an Associate Professor of Pediatrics, in addition to being a Professor of Medicine, and a scientist for the UAB Comprehensive Cancer Center.

For more information on Dr. Lamb, please click here.

Richard Lopez, MD

Associate Professor and Director of Translational Research                                      

Dr. Saad received his MD degree from Ain Shams University in Cairo, Egypt.  He has been affiliated with Wayne State University in Detroit, Michigan, Maryland General Hospital at the University of Maryland Medical System, West Virginia University, and the Medical College of Wisconsin, before joining UAB.

His research focuses on hematopoietic stem cell transplantation for different hematological diseases and utilizing graft manipulation to improve the outcome of transplant. He has authored several articles and book chapters.

For more information about Dr. Saad, please click here.

Dr. Vaughan is recognized as an international leader in the development of safer preparative regimens for bone marrow transplantation through pharmacokinetics directed dosing. He continues his clinical trial work in high dose chemotherapy and hematopoietic stem cell transplantation. 

Dr. Vaughan received his MD degree from the University of Connecticut School of Medicine.  He has been affiliated with The Johns Hopkins University School of Medicine, the University of Nebraska Medical Center, and Eppley Cancer Institute in Omaha, NE, before establishing the Bone Marrow Transplantation & Cell Therapy Program at UAB, serving as the director from 1991 to 2012.

For more information about Dr. Vaughan, please click here.